Acute Sinusitis Market was valued at US$ 3.11 Bn. in 2022. Global Acute Sinusitis Market size is estimated to grow at a CAGR of 6.25%.Acute Sinusitis Market Overview:
Acute sinusitis is a temporary condition, which can be treated with antibiotics and decongestants. The symptoms of acute sinusitis include bad breath, cough, dental pain, diminished sense of smell, facial pain/pressure, fatigue, fever, nasal discharge, and nasal obstruction. Acute sinusitis is mostly caused by the common cold. Acute sinusitis is also known as acute rhinosinusitis, which is a short-term inflammation of the membranes, line on the nose and surrounding sinuses. It impedes the ability to drain mucus from the nose and sinuses.To know about the Research Methodology :- Request Free Sample Report The sinusitis has found in acute or chronic sinusitis, with different germs like bacteria and viruses blocking the nasal cavities. Sinusitis can form complications like a brain abscess and meningitis. The presence of diagnostic treatment methods like Blood tests, ciliary function tests, nasal cytology & allergy testing, sinus CT scans, and sinus MRIs are helping to reduce acute sinusitis. Healthcare service provider are focusing on the deployment of treatment of sinusitis. Key players operating in the market are concentrating on development of the devices that improve intra-nasal drug delivery using innovative devices and help to reduce side effects of antibiotics. Med-tech companies are boosting their R&D capacities to develop sinusitis treatment devices, which deploy bi-directional exhalation.
Dynamics:
Number of people suffering from acute sinusitis, presence of treatment and diagnostic options are expected to drive market growth. The technological advancement in diagnostic tests and the use of various medications for the treatment like nasal sprays, nasal corticosteroids, and decongestants are some of the driving factors behind the market growth. With the rising prevalence rate of sinusitis, use of medical devices for disease diagnosis and treatment are increasing. An increase in usages of various medications for treatment such as nasal sprays, nasal corticosteroids, and decongestants are expected to boost the market growth. Sinusitis Surgery is expected to drive the market growth Sinus surgery is a procedure, which aims to open the pathways of the sinuses and clear blockages. It is a suitable option for people, who have suffered with ongoing and recurrent sinus infections or abnormal growths in the sinus. The goal of the surgery is to confiscate whatever is blocking of the sinuses. Sinusitis disease has affected millions of people every year and it is becoming a major health problem. It is usually caused by infection like bacteria, and viruses, chemical, allergies, and autoimmune problems. The sinus surgery helps to remove the unhealthy sinus tissue. The technological advancements in sinusitis surgery like surgical laser technologies are improving the life of patients and offer few side-effects.Segment Analysis:
Antibiotics segment: Hold the dominant share in the Market Based on the treatment of sinusitis, market is segmented into allergen immunotherapy, antibiotics, antihistamines and decongestants, expectorants, nasal corticosteroids and oral corticosteroids. Antibiotics are recommended for bacterial sinusitis. It involves the frontal, sphenoid, or ethmoid sinuses, which can produce more serious problems. Key players operating in the market are stepping up their R&D efforts to offer better alternative solutions for patients, who are suffering with sinusitis. The chronic sinusitis segment is expected to grow at a more than 4.24% rate of CAGR in the global market. If the symptoms of sinusitis continue for 12 weeks or longer, the doctor may diagnose chronic sinusitis. Chronic sinusitis is not generally bacterial in nature, so antibiotics are implausible to resolve symptoms. Corticosteroid sprays can benefit in recurrent cases, which mandatory require a prescription and medical supervision.Acute Sinusitis Market Regional Insights:
North America is expected to contribute more than 35% share in the market. North America market growth is driven by increasing occurrence of chronic diseases and technological advancements in diagnostic testing. Sinus infection is a major health problem. Sinusitis impacts approximately more than 30 million adults annually in the United States alone. Americans spend more than $1 billion on over-the-counter medications to treat sinusitis every year. Presence of well-established healthcare infrastructure, number of patients suffering from acute sinusitis are expected to boost the North America market growth. The emergence of biologics is one of the key trends in the global market. Currently, omalizumab has evolved as the most suitable candidate. Omalizumab is a drug, which recombinant humanized monoclonal antibody. This drug has been approved for the treatment of severe allergic asthma in the US and Europe. Scientists are assessing Omalizumab on the parameters of safety and efficacy for the treatment of chronic rhinosinusitis with nasal polyps. The successful launch of biologics like omalizumab is expected to drive growth in the global market. Key players are gradually stepped up their investment in innovations and marketing across the globe, thanks to continuous focus on cost management, higher efficiency of process. For instance, in 2021, Clinic Barcelona have carried out different clinical trials with monoclonal antibodies, which are effective form of precision medicine. The objective of the report is to present a comprehensive analysis of the global Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The reports also help in understanding the Market dynamic, structure by analyzing the market segments and projecting the Market size. Clear representation of competitive analysis of key players by Application, price, financial position, product portfolio, growth strategies, and regional presence in the Market make the report investor’s guide.Acute Sinusitis Market Scope: Inquire before buying
Acute Sinusitis Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2018 to 2022 Market Size in 2022: US $ 3.11 Bn. Forecast Period 2023 to 2029 CAGR: 6.25% Market Size in 2029: US $ 4.75 Bn. Segments Covered: by Type of Sinusitis Acute Sinusitis Sub-acute Sinusitis Chronic Sinusitis by Treatment of Sinusitis Allergen Immunotherapy Antibiotics Antihistamines and Decongestants Expectorants Nasal Corticosteroids Oral Corticosteroids by End User Hospitals & Clinics ENTC Specialists Research Institute Others Acute Sinusitis Market, by Region
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) North America (United States, Canada and Mexico) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America) Key Players 1. Bayer AG 2. AstraZeneca Plc 3. Eli Lilly And Company 4. Bristol-Myers Squibb 5. Sanofi 6. Abbott 7. Merck & Co, Inc. 8. Reddy’s Laboratory 9. Novartis AG 10. Fresenius Kabi AG 11. Teva Pharmaceutical Industries Ltd. 12. Pfizer Inc. 13. Johnson & Johnson Services, Inc. 14. Sun Pharmaceutical Industries Ltd 15. Dr. Reddy’s Laboratories Ltd 16. Amgen Inc. 17. Beximco Pharmaceuticals Ltd 18. Zydus Cadila 29. Bionorica SE Frequently Asked Questions: 1] What segments are covered in the Acute Sinusitis Market report? Ans. The segments covered in the Market report are based on Type of Sinusitis, Treatment of Sinusitis, and Application. 2] Which region is expected to hold the highest share in the Acute Sinusitis Market? Ans. The North America region is expected to hold the highest share in the Market. 3] What is the market size of the Acute Sinusitis Market by 2029? Ans. The market size of the Market by 2029 is US$ 4.75 Bn. 4] What is the forecast period for the Acute Sinusitis Market? Ans. The forecast period for the Market is 2023-2029. 5] What was the market size of the Acute Sinusitis Market in 2022? Ans. The market size of the Market in 2022 was US$ 3.11 Bn.
Global Acute Sinusitis Market
Table of Content 1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Acute Sinusitis Market Size, by Market Value (US$ Bn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global Acute Sinusitis Market Analysis and Forecast 6.1. Global Acute Sinusitis Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Acute Sinusitis Market Analysis and Forecast, by Type of Sinusitis 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Acute Sinusitis Market Value Share Analysis, by Type of Sinusitis 7.4. Global Acute Sinusitis Market Size (US$ Bn) Forecast, by Type of Sinusitis 7.5. Global Acute Sinusitis Market Analysis, by Type of Sinusitis 7.6. Global Acute Sinusitis Market Attractiveness Analysis, by Type of Sinusitis 8. Global Acute Sinusitis Market Analysis and Forecast, by Treatment of Sinusitis 8.1. Introduction and Definition 8.2. Key Findings 8.3. Global Acute Sinusitis Market Value Share Analysis, by Treatment of Sinusitis 8.4. Global Acute Sinusitis Market Size (US$ Bn) Forecast, by Treatment of Sinusitis 8.5. Global Acute Sinusitis Market Analysis, by Treatment of Sinusitis 8.6. Global Acute Sinusitis Market Attractiveness Analysis, by Treatment of Sinusitis 9. Global Acute Sinusitis Market Analysis and Forecast, by End User 9.1. Introduction and Definition 9.2. Key Findings 9.3. Global Acute Sinusitis Market Value Share Analysis, by End User 9.4. Global Acute Sinusitis Market Size (US$ Bn) Forecast, by End User 9.5. Global Acute Sinusitis Market Analysis, by End User 9.6. Global Acute Sinusitis Market Attractiveness Analysis, by End User 10. Global Acute Sinusitis Market Analysis, by Region 10.1. Global Acute Sinusitis Market Value Share Analysis, by Region 10.2. Global Acute Sinusitis Market Size (US$ Bn) Forecast, by Region 10.3. Global Acute Sinusitis Market Attractiveness Analysis, by Region 11. North America Acute Sinusitis Market Analysis 11.1. Key Findings 11.2. North America Acute Sinusitis Market Overview 11.3. North America Acute Sinusitis Market Value Share Analysis, by Type of Sinusitis 11.4. North America Acute Sinusitis Market Forecast, by Type of Sinusitis 11.4.1. Acute Sinusitis 11.4.2. Sub-acute Sinusitis 11.4.3. Chronic Sinusitis 11.5. North America Acute Sinusitis Market Value Share Analysis, by Treatment of Sinusitis 11.6. North America Acute Sinusitis Market Forecast, by Treatment of Sinusitis 11.6.1. Allergen Immunotherapy 11.6.2. Antibiotics 11.6.3. Antihistamines and Decongestants 11.6.4. Expectorants 11.6.5. Nasal Corticosteroids 11.6.6. Oral Corticosteroids 11.7. North America Acute Sinusitis Market Value Share Analysis, by End User 11.8. North America Acute Sinusitis Market Forecast, by End User 11.8.1. Hospitals & Clinics 11.8.2. ENTC Specialists 11.8.3. Research Institute 11.8.4. Others 11.9. North America Acute Sinusitis Market Value Share Analysis, by Country 11.10. North America Acute Sinusitis Market Forecast, by Country 11.10.1. U.S. 11.10.2. Canada 11.11. North America Acute Sinusitis Market Analysis, by Country 11.12. U.S. Acute Sinusitis Market Forecast, by Type of Sinusitis 11.12.1. Acute Sinusitis 11.12.2. Sub-acute Sinusitis 11.12.3. Chronic Sinusitis 11.13. U.S. Acute Sinusitis Market Forecast, by Treatment of Sinusitis 11.13.1. Allergen Immunotherapy 11.13.2. Antibiotics 11.13.3. Antihistamines and Decongestants 11.13.4. Expectorants 11.13.5. Nasal Corticosteroids 11.13.6. Oral Corticosteroids 11.14. U.S. Acute Sinusitis Market Forecast, by End User 11.14.1. Hospitals & Clinics 11.14.2. ENTC Specialists 11.14.3. Research Institute 11.14.4. Others 11.15. Canada Acute Sinusitis Market Forecast, by Type of Sinusitis 11.15.1. Acute Sinusitis 11.15.2. Sub-acute Sinusitis 11.15.3. Chronic Sinusitis 11.16. Canada Acute Sinusitis Market Forecast, by Treatment of Sinusitis 11.16.1. Allergen Immunotherapy 11.16.2. Antibiotics 11.16.3. Antihistamines and Decongestants 11.16.4. Expectorants 11.16.5. Nasal Corticosteroids 11.16.6. Oral Corticosteroids 11.17. Canada Acute Sinusitis Market Forecast, by End User 11.17.1. Hospitals & Clinics 11.17.2. ENTC Specialists 11.17.3. Research Institute 11.17.4. Others 11.18. North America Acute Sinusitis Market Attractiveness Analysis 11.18.1. By Type of Sinusitis 11.18.2. By Treatment of Sinusitis 11.18.3. By End User 11.19. PEST Analysis 11.20. Key Trends 11.21. Key Developments 12. Europe Acute Sinusitis Market Analysis 12.1. Key Findings 12.2. Europe Acute Sinusitis Market Overview 12.3. Europe Acute Sinusitis Market Value Share Analysis, by Type of Sinusitis 12.4. Europe Acute Sinusitis Market Forecast, by Type of Sinusitis 12.4.1. Acute Sinusitis 12.4.2. Sub-acute Sinusitis 12.4.3. Chronic Sinusitis 12.5. Europe Acute Sinusitis Market Value Share Analysis, by Treatment of Sinusitis 12.6. Europe Acute Sinusitis Market Forecast, by Treatment of Sinusitis 12.6.1. Allergen Immunotherapy 12.6.2. Antibiotics 12.6.3. Antihistamines and Decongestants 12.6.4. Expectorants 12.6.5. Nasal Corticosteroids 12.6.6. Oral Corticosteroids 12.7. Europe Acute Sinusitis Market Value Share Analysis, by End User 12.8. Europe Acute Sinusitis Market Forecast, by End User 12.8.1. Hospitals & Clinics 12.8.2. ENTC Specialists 12.8.3. Research Institute 12.8.4. Others 12.9. Europe Acute Sinusitis Market Value Share Analysis, by Country 12.10. Europe Acute Sinusitis Market Forecast, by Country 12.10.1. Germany 12.10.2. U.K. 12.10.3. France 12.10.4. Italy 12.10.5. Spain 12.10.6. Rest of Europe 12.11. Europe Acute Sinusitis Market Analysis, by Country 12.12. Germany Acute Sinusitis Market Forecast, by Type of Sinusitis 12.12.1. Acute Sinusitis 12.12.2. Sub-acute Sinusitis 12.12.3. Chronic Sinusitis 12.13. Germany Acute Sinusitis Market Forecast, by Treatment of Sinusitis 12.13.1. Allergen Immunotherapy 12.13.2. Antibiotics 12.13.3. Antihistamines and Decongestants 12.13.4. Expectorants 12.13.5. Nasal Corticosteroids 12.13.6. Oral Corticosteroids 12.14. Germany Acute Sinusitis Market Forecast, by End User 12.14.1. Hospitals & Clinics 12.14.2. ENTC Specialists 12.14.3. Research Institute 12.14.4. Others 12.15. U.K. Acute Sinusitis Market Forecast, by Type of Sinusitis 12.15.1. Acute Sinusitis 12.15.2. Sub-acute Sinusitis 12.15.3. Chronic Sinusitis 12.16. U.K. Acute Sinusitis Market Forecast, by Treatment of Sinusitis 12.16.1. Allergen Immunotherapy 12.16.2. Antibiotics 12.16.3. Antihistamines and Decongestants 12.16.4. Expectorants 12.16.5. Nasal Corticosteroids 12.16.6. Oral Corticosteroids 12.17. U.K. Acute Sinusitis Market Forecast, by End User 12.17.1. Hospitals & Clinics 12.17.2. ENTC Specialists 12.17.3. Research Institute 12.17.4. Others 12.18. France Acute Sinusitis Market Forecast, by Type of Sinusitis 12.18.1. Acute Sinusitis 12.18.2. Sub-acute Sinusitis 12.18.3. Chronic Sinusitis 12.19. France Acute Sinusitis Market Forecast, by Treatment of Sinusitis 12.19.1. Allergen Immunotherapy 12.19.2. Antibiotics 12.19.3. Antihistamines and Decongestants 12.19.4. Expectorants 12.19.5. Nasal Corticosteroids 12.19.6. Oral Corticosteroids 12.20. France Acute Sinusitis Market Forecast, by End User 12.20.1. Hospitals & Clinics 12.20.2. ENTC Specialists 12.20.3. Research Institute 12.20.4. Others 12.21. Italy Acute Sinusitis Market Forecast, by Type of Sinusitis 12.21.1. Acute Sinusitis 12.21.2. Sub-acute Sinusitis 12.21.3. Chronic Sinusitis 12.22. Italy Acute Sinusitis Market Forecast, by Treatment of Sinusitis 12.22.1. Allergen Immunotherapy 12.22.2. Antibiotics 12.22.3. Antihistamines and Decongestants 12.22.4. Expectorants 12.22.5. Nasal Corticosteroids 12.22.6. Oral Corticosteroids 12.23. Italy Acute Sinusitis Market Forecast, by End User 12.23.1. Hospitals & Clinics 12.23.2. ENTC Specialists 12.23.3. Research Institute 12.23.4. Others 12.24. Spain Acute Sinusitis Market Forecast, by Type of Sinusitis 12.24.1. Acute Sinusitis 12.24.2. Sub-acute Sinusitis 12.24.3. Chronic Sinusitis 12.25. Spain Acute Sinusitis Market Forecast, by Treatment of Sinusitis 12.25.1. Allergen Immunotherapy 12.25.2. Antibiotics 12.25.3. Antihistamines and Decongestants 12.25.4. Expectorants 12.25.5. Nasal Corticosteroids 12.25.6. Oral Corticosteroids 12.26. Spain Acute Sinusitis Market Forecast, by End User 12.26.1. Hospitals & Clinics 12.26.2. ENTC Specialists 12.26.3. Research Institute 12.26.4. Others 12.27. Rest of Europe Acute Sinusitis Market Forecast, by Type of Sinusitis 12.27.1. Acute Sinusitis 12.27.2. Sub-acute Sinusitis 12.27.3. Chronic Sinusitis 12.28. Rest of Europe Acute Sinusitis Market Forecast, by Treatment of Sinusitis 12.28.1. Allergen Immunotherapy 12.28.2. Antibiotics 12.28.3. Antihistamines and Decongestants 12.28.4. Expectorants 12.28.5. Nasal Corticosteroids 12.28.6. Oral Corticosteroids 12.29. Rest Of Europe Acute Sinusitis Market Forecast, by End User 12.29.1. Hospitals & Clinics 12.29.2. ENTC Specialists 12.29.3. Research Institute 12.29.4. Others 12.30. Europe Acute Sinusitis Market Attractiveness Analysis 12.30.1. By Type of Sinusitis 12.30.2. By Treatment of Sinusitis 12.30.3. By End User 12.31. PEST Analysis 12.32. Key Trends 12.33. Key Developments 13. Asia Pacific Acute Sinusitis Market Analysis 13.1. Key Findings 13.2. Asia Pacific Acute Sinusitis Market Overview 13.3. Asia Pacific Acute Sinusitis Market Value Share Analysis, by Type of Sinusitis 13.4. Asia Pacific Acute Sinusitis Market Forecast, by Type of Sinusitis 13.4.1. Acute Sinusitis 13.4.2. Sub-acute Sinusitis 13.4.3. Chronic Sinusitis 13.5. Asia Pacific Acute Sinusitis Market Value Share Analysis, by Treatment of Sinusitis 13.6. Asia Pacific Acute Sinusitis Market Forecast, by Treatment of Sinusitis 13.6.1. Allergen Immunotherapy 13.6.2. Antibiotics 13.6.3. Antihistamines and Decongestants 13.6.4. Expectorants 13.6.5. Nasal Corticosteroids 13.6.6. Oral Corticosteroids 13.7. Asia Pacific Acute Sinusitis Market Value Share Analysis, by End User 13.8. Asia Pacific Acute Sinusitis Market Forecast, by End User 13.8.1. Hospitals & Clinics 13.8.2. ENTC Specialists 13.8.3. Research Institute 13.8.4. Others 13.9. Asia Pacific Acute Sinusitis Market Value Share Analysis, by Country 13.10. Asia Pacific Acute Sinusitis Market Forecast, by Country 13.10.1. China 13.10.2. India 13.10.3. Japan 13.10.4. ASEAN 13.10.5. Rest of Asia Pacific 13.11. Asia Pacific Acute Sinusitis Market Analysis, by Country 13.12. China Acute Sinusitis Market Forecast, by Type of Sinusitis 13.12.1. Acute Sinusitis 13.12.2. Sub-acute Sinusitis 13.12.3. Chronic Sinusitis 13.13. China Acute Sinusitis Market Forecast, by Treatment of Sinusitis 13.13.1. Allergen Immunotherapy 13.13.2. Antibiotics 13.13.3. Antihistamines and Decongestants 13.13.4. Expectorants 13.13.5. Nasal Corticosteroids 13.13.6. Oral Corticosteroids 13.14. China Acute Sinusitis Market Forecast, by End User 13.14.1. Hospitals & Clinics 13.14.2. ENTC Specialists 13.14.3. Research Institute 13.14.4. Others 13.15. India Acute Sinusitis Market Forecast, by Type of Sinusitis 13.15.1. Acute Sinusitis 13.15.2. Sub-acute Sinusitis 13.15.3. Chronic Sinusitis 13.16. India Acute Sinusitis Market Forecast, by Treatment of Sinusitis 13.16.1. Allergen Immunotherapy 13.16.2. Antibiotics 13.16.3. Antihistamines and Decongestants 13.16.4. Expectorants 13.16.5. Nasal Corticosteroids 13.16.6. Oral Corticosteroids 13.17. India Acute Sinusitis Market Forecast, by End User 13.17.1. Hospitals & Clinics 13.17.2. ENTC Specialists 13.17.3. Research Institute 13.17.4. Others 13.18. Japan Acute Sinusitis Market Forecast, by Type of Sinusitis 13.18.1. Acute Sinusitis 13.18.2. Sub-acute Sinusitis 13.18.3. Chronic Sinusitis 13.19. Japan Acute Sinusitis Market Forecast, by Treatment of Sinusitis 13.19.1. Allergen Immunotherapy 13.19.2. Antibiotics 13.19.3. Antihistamines and Decongestants 13.19.4. Expectorants 13.19.5. Nasal Corticosteroids 13.19.6. Oral Corticosteroids 13.20. Japan Acute Sinusitis Market Forecast, by End User 13.20.1. Hospitals & Clinics 13.20.2. ENTC Specialists 13.20.3. Research Institute 13.20.4. Others 13.21. ASEAN Acute Sinusitis Market Forecast, by Type of Sinusitis 13.21.1. Acute Sinusitis 13.21.2. Sub-acute Sinusitis 13.21.3. Chronic Sinusitis 13.22. ASEAN Acute Sinusitis Market Forecast, by Treatment of Sinusitis 13.22.1. Allergen Immunotherapy 13.22.2. Antibiotics 13.22.3. Antihistamines and Decongestants 13.22.4. Expectorants 13.22.5. Nasal Corticosteroids 13.22.6. Oral Corticosteroids 13.23. ASEAN Acute Sinusitis Market Forecast, by End User 13.23.1. Hospitals & Clinics 13.23.2. ENTC Specialists 13.23.3. Research Institute 13.23.4. Others 13.24. Rest of Asia Pacific Acute Sinusitis Market Forecast, by Type of Sinusitis 13.24.1. Acute Sinusitis 13.24.2. Sub-acute Sinusitis 13.24.3. Chronic Sinusitis 13.25. Rest of Asia Pacific Acute Sinusitis Market Forecast, by Treatment of Sinusitis 13.25.1. Allergen Immunotherapy 13.25.2. Antibiotics 13.25.3. Antihistamines and Decongestants 13.25.4. Expectorants 13.25.5. Nasal Corticosteroids 13.25.6. Oral Corticosteroids 13.26. Rest of Asia Pacific Acute Sinusitis Market Forecast, by End User 13.26.1. Hospitals & Clinics 13.26.2. ENTC Specialists 13.26.3. Research Institute 13.26.4. Others 13.27. Asia Pacific Acute Sinusitis Market Attractiveness Analysis 13.27.1. By Type of Sinusitis 13.27.2. By Treatment of Sinusitis 13.27.3. By End User 13.28. PEST Analysis 13.29. Key Trends 13.30. Key Developments 14. Middle East & Africa Acute Sinusitis Market Analysis 14.1. Key Findings 14.2. Middle East & Africa Acute Sinusitis Market Overview 14.3. Middle East & Africa Acute Sinusitis Market Value Share Analysis, by Type of Sinusitis 14.4. Middle East & Africa Acute Sinusitis Market Forecast, by Type of Sinusitis 14.4.1. Acute Sinusitis 14.4.2. Sub-acute Sinusitis 14.4.3. Chronic Sinusitis 14.5. Middle East & Africa Acute Sinusitis Market Value Share Analysis, by Treatment of Sinusitis 14.6. Middle East & Africa Acute Sinusitis Market Forecast, by Treatment of Sinusitis 14.6.1. Allergen Immunotherapy 14.6.2. Antibiotics 14.6.3. Antihistamines and Decongestants 14.6.4. Expectorants 14.6.5. Nasal Corticosteroids 14.6.6. Oral Corticosteroids 14.7. Middle East & Africa Acute Sinusitis Market Value Share Analysis, by End User 14.8. Middle East & Africa Acute Sinusitis Market Forecast, by End User 14.8.1. Hospitals & Clinics 14.8.2. ENTC Specialists 14.8.3. Research Institute 14.8.4. Others 14.9. Middle East & Africa Acute Sinusitis Market Value Share Analysis, by Country 14.10. Middle East & Africa Acute Sinusitis Market Forecast, by Country 14.10.1. GCC 14.10.2. South Africa 14.10.3. Rest of Middle East & Africa 14.11. Middle East & Africa Acute Sinusitis Market Analysis, by Country 14.12. GCC Acute Sinusitis Market Forecast, by Type of Sinusitis 14.12.1. Acute Sinusitis 14.12.2. Sub-acute Sinusitis 14.12.3. Chronic Sinusitis 14.13. GCC Acute Sinusitis Market Forecast, by Treatment of Sinusitis 14.13.1. Allergen Immunotherapy 14.13.2. Antibiotics 14.13.3. Antihistamines and Decongestants 14.13.4. Expectorants 14.13.5. Nasal Corticosteroids 14.13.6. Oral Corticosteroids 14.14. GCC Acute Sinusitis Market Forecast, by End User 14.14.1. Hospitals & Clinics 14.14.2. ENTC Specialists 14.14.3. Research Institute 14.14.4. Others 14.15. South Africa Acute Sinusitis Market Forecast, by Type of Sinusitis 14.15.1. Acute Sinusitis 14.15.2. Sub-acute Sinusitis 14.15.3. Chronic Sinusitis 14.16. South Africa Acute Sinusitis Market Forecast, by Treatment of Sinusitis 14.16.1. Allergen Immunotherapy 14.16.2. Antibiotics 14.16.3. Antihistamines and Decongestants 14.16.4. Expectorants 14.16.5. Nasal Corticosteroids 14.16.6. Oral Corticosteroids 14.17. South Africa Acute Sinusitis Market Forecast, by End User 14.17.1. Hospitals & Clinics 14.17.2. ENTC Specialists 14.17.3. Research Institute 14.17.4. Others 14.18. Rest of Middle East & Africa Acute Sinusitis Market Forecast, by Type of Sinusitis 14.18.1. Acute Sinusitis 14.18.2. Sub-acute Sinusitis 14.18.3. Chronic Sinusitis 14.19. Rest of Middle East & Africa Acute Sinusitis Market Forecast, by Treatment of Sinusitis 14.19.1. Allergen Immunotherapy 14.19.2. Antibiotics 14.19.3. Antihistamines and Decongestants 14.19.4. Expectorants 14.19.5. Nasal Corticosteroids 14.19.6. Oral Corticosteroids 14.20. Rest of Middle East & Africa Acute Sinusitis Market Forecast, by End User 14.20.1. Hospitals & Clinics 14.20.2. ENTC Specialists 14.20.3. Research Institute 14.20.4. Others 14.21. Middle East & Africa Acute Sinusitis Market Attractiveness Analysis 14.21.1. By Type of Sinusitis 14.21.2. By Treatment of Sinusitis 14.21.3. By End User 14.22. PEST Analysis 14.23. Key Trends 14.24. Key Developments 15. South America Acute Sinusitis Market Analysis 15.1. Key Findings 15.2. South America Acute Sinusitis Market Overview 15.3. South America Acute Sinusitis Market Value Share Analysis, by Type of Sinusitis 15.4. South America Acute Sinusitis Market Forecast, by Type of Sinusitis 15.4.1. Acute Sinusitis 15.4.2. Sub-acute Sinusitis 15.4.3. Chronic Sinusitis 15.5. South America Acute Sinusitis Market Value Share Analysis, by Treatment of Sinusitis 15.6. South America Acute Sinusitis Market Forecast, by Treatment of Sinusitis 15.6.1. Allergen Immunotherapy 15.6.2. Antibiotics 15.6.3. Antihistamines and Decongestants 15.6.4. Expectorants 15.6.5. Nasal Corticosteroids 15.6.6. Oral Corticosteroids 15.7. South America Acute Sinusitis Market Value Share Analysis, by End User 15.8. South America Acute Sinusitis Market Forecast, by End User 15.8.1. Hospitals & Clinics 15.8.2. ENTC Specialists 15.8.3. Research Institute 15.8.4. Others 15.9. South America Acute Sinusitis Market Value Share Analysis, by Country 15.10. South America Acute Sinusitis Market Forecast, by Country 15.10.1. Brazil 15.10.2. Mexico 15.10.3. Rest of South America 15.11. South America Acute Sinusitis Market Analysis, by Country 15.12. Brazil Acute Sinusitis Market Forecast, by Type of Sinusitis 15.12.1. Acute Sinusitis 15.12.2. Sub-acute Sinusitis 15.12.3. Chronic Sinusitis 15.13. Brazil Acute Sinusitis Market Forecast, by Treatment of Sinusitis 15.13.1. Allergen Immunotherapy 15.13.2. Antibiotics 15.13.3. Antihistamines and Decongestants 15.13.4. Expectorants 15.13.5. Nasal Corticosteroids 15.13.6. Oral Corticosteroids 15.14. Brazil Acute Sinusitis Market Forecast, by End User 15.14.1. Hospitals & Clinics 15.14.2. ENTC Specialists 15.14.3. Research Institute 15.14.4. Others 15.15. Mexico Acute Sinusitis Market Forecast, by Type of Sinusitis 15.15.1. Acute Sinusitis 15.15.2. Sub-acute Sinusitis 15.15.3. Chronic Sinusitis 15.16. Mexico Acute Sinusitis Market Forecast, by Treatment of Sinusitis 15.16.1. Allergen Immunotherapy 15.16.2. Antibiotics 15.16.3. Antihistamines and Decongestants 15.16.4. Expectorants 15.16.5. Nasal Corticosteroids 15.16.6. Oral Corticosteroids 15.17. Mexico Acute Sinusitis Market Forecast, by End User 15.17.1. Hospitals & Clinics 15.17.2. ENTC Specialists 15.17.3. Research Institute 15.17.4. Others 15.18. Rest of South America Acute Sinusitis Market Forecast, by Type of Sinusitis 15.18.1. Acute Sinusitis 15.18.2. Sub-acute Sinusitis 15.18.3. Chronic Sinusitis 15.19. Rest of South America Acute Sinusitis Market Forecast, by Treatment of Sinusitis 15.19.1. Allergen Immunotherapy 15.19.2. Antibiotics 15.19.3. Antihistamines and Decongestants 15.19.4. Expectorants 15.19.5. Nasal Corticosteroids 15.19.6. Oral Corticosteroids 15.20. Rest of South America Acute Sinusitis Market Forecast, by End User 15.20.1. Hospitals & Clinics 15.20.2. ENTC Specialists 15.20.3. Research Institute 15.20.4. Others 15.21. South America Acute Sinusitis Market Attractiveness Analysis 15.21.1. By Type of Sinusitis 15.21.2. By Treatment of Sinusitis 15.21.3. By End User 15.22. PEST Analysis 15.23. Key Trends 15.24. Key Developments 16. Company Profiles 16.1. Market Share Analysis, by Company 16.2. Competition Matrix 16.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 16.2.2. New Product Launches and Product Enhancements 16.2.3. Market Consolidation 16.2.3.1. M&A by Regions, Investment and Applications 16.2.3.2. M&A Key Players, Forward Integration and Backward Integration 16.3. Company Profiles: Key Players 16.3.1. Bayer AG 16.3.1.1. Company Overview 16.3.1.2. Financial Overview 16.3.1.3. Portfolio 16.3.1.4. Business Strategy 16.3.1.5. Recent Developments 16.3.1.6. Developing Footprint 16.3.2. AstraZeneca Plc 16.3.3. Eli Lilly And Company 16.3.4. Bristol-Myers Squibb 16.3.5. Sanofi 16.3.6. Abbott 16.3.7. Merck & Co, Inc. 16.3.8. Reddy’s Laboratory 16.3.9. Novartis AG 16.3.10. Sanofi 16.3.11. Fresenius Kabi AG 16.3.12. Teva Pharmaceutical Industries Ltd. 16.3.13. Pfizer Inc. 16.3.14. Johnson & Johnson Services, Inc. 16.3.15. Sun Pharmaceutical Industries Ltd 16.3.16. Dr. Reddy’s Laboratories Ltd 16.3.17. Amgen Inc. 16.3.18. Beximco Pharmaceuticals Ltd 16.3.19. Zydus Cadila 16.3.20. Bionorica SE 17. Primary Key Insights